Anti-fungal drug, Cresemba, approved for treating rare fungal infections

March 6, 2015 7:32 PM

13 0

Posted by Staff on March 6, 2015 //

The U.S. Food and Drug Administration today approved Cresemba (isavuconazonium sulfate), a new antifungal drug product used to treat adults with invasive aspergillosis and invasive mucormycosis, rare but serious infections.

Read more

To category page